- Home
- XERS vs EVLV Comparison
XERS vs EVLV Comparison
Compare XERS & EVLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XERS
- EVLV
- Stock Information
- Founded
- XERS 2005
- EVLV 2013
- Country
- XERS United States
- EVLV United States
- Employees
- XERS N/A
- EVLV N/A
- Industry
- XERS Biotechnology: Pharmaceutical Preparations
- EVLV Computer peripheral equipment
- Sector
- XERS Health Care
- EVLV Technology
- Exchange
- XERS Nasdaq
- EVLV Nasdaq
- Market Cap
- XERS 752.7M
- EVLV 671.9M
- IPO Year
- XERS 2018
- EVLV N/A
- Fundamental
- Price
- XERS $5.11
- EVLV $5.69
- Analyst Decision
- XERS Strong Buy
- EVLV Buy
- Analyst Count
- XERS 6
- EVLV 2
- Target Price
- XERS $6.25
- EVLV $6.50
- AVG Volume (30 Days)
- XERS 2.0M
- EVLV 2.7M
- Earning Date
- XERS 08-07-2025
- EVLV 08-14-2025
- Dividend Yield
- XERS N/A
- EVLV N/A
- EPS Growth
- XERS N/A
- EVLV N/A
- EPS
- XERS N/A
- EVLV N/A
- Revenue
- XERS $222,551,000.00
- EVLV $113,691,000.00
- Revenue This Year
- XERS $35.03
- EVLV $25.98
- Revenue Next Year
- XERS $18.31
- EVLV $19.21
- P/E Ratio
- XERS N/A
- EVLV N/A
- Revenue Growth
- XERS 29.88
- EVLV 36.70
- 52 Week Low
- XERS $2.10
- EVLV $2.04
- 52 Week High
- XERS $6.07
- EVLV $6.45
- Technical
- Relative Strength Index (RSI)
- XERS 61.48
- EVLV 50.01
- Support Level
- XERS $4.62
- EVLV $5.71
- Resistance Level
- XERS $5.39
- EVLV $6.06
- Average True Range (ATR)
- XERS 0.21
- EVLV 0.26
- MACD
- XERS 0.07
- EVLV -0.07
- Stochastic Oscillator
- XERS 71.72
- EVLV 16.94
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About EVLV Evolv Technologies Holdings Inc.
Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.